Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Omeprazole for Bleeding Peptic Ulcer
NCT04170270Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Nov 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of omeprazole in peptic ulcer disease (PUD), sponsored by Assiut University. Primary endpoint: recurrent bleeding at 15 days. Status: unknown.
02
Drugs
omeprazole
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT04170270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170270.